Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NuCana PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NCNA
Nasdaq
8731
https://www.nucana.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NuCana PLC (ADR)
NuCana Announces Completion of ADS Ratio Change
- Apr 16th, 2024 12:00 pm
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
- Apr 9th, 2024 8:30 pm
NuCana Announces Plan to Implement ADS Ratio Change
- Mar 27th, 2024 8:30 pm
NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
- Mar 20th, 2024 8:01 pm
NuCana (NASDAQ:NCNA) Will Have To Spend Its Cash Wisely
- Mar 14th, 2024 12:03 pm
NuCana to Present at TD Cowen’s 44th Annual Health Care Conference
- Feb 27th, 2024 1:00 pm
NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update
- Nov 16th, 2023 9:01 pm
NuCana Announces Listing Transfer to Nasdaq Capital Market
- Nov 10th, 2023 9:01 pm
NuCana to Present at the Jefferies London Healthcare Conference
- Nov 8th, 2023 9:01 pm
NuCana to Participate in the Truist Securities 2023 BioPharma Symposium
- Nov 1st, 2023 8:01 pm
NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- Oct 16th, 2023 11:00 am
NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- Oct 13th, 2023 4:30 pm
Bears are Losing Control Over NuCana PLC Sponsored ADR (NCNA), Here's Why It's a 'Buy' Now
- Sep 28th, 2023 1:55 pm
NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- Sep 18th, 2023 12:00 pm
Here's Why We're Watching NuCana's (NASDAQ:NCNA) Cash Burn Situation
- Aug 31st, 2023 4:11 pm
NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update
- Aug 16th, 2023 8:01 pm
NuCana to Present at the Jefferies Healthcare Conference
- Jun 1st, 2023 12:00 pm
NuCana Reports First Quarter 2023 Financial Results and Provides Business Update
- May 17th, 2023 8:01 pm
NuCana Announces Receipt of Nasdaq Notice
- May 12th, 2023 8:01 pm
Scroll